Diversion Control Homepage Diversion Control Homepage Privacy Policy Contact Us What's New Hot Items Site Map Search Diversion SiteDEA Diversion Control Program Logo and Banner

Federal Register Notices > Notice of Registration - 2005 Cambrex North Brunswick Inc.

Notice of Registration - 2005 


FR Doc 05-4212 [Federal Register: March 4, 2005 (Volume 70, Number 42)] [Notices] [Page 10675-10676] From the Federal Register Online via GPO Access [wais.access.gpo.gov] [DOCID:fr04mr05-100]


DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Manufacturer of Controlled Substances Notice of Registration

By Notice dated October 1, 2004, and published in the Federal Register on October 29, 2004, (69 FR 63178), Cambrex North Brunswick Inc., Technology Center of New Jersey, 661 Highway One, North Brunswick, New Jersey 08902, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in Schedules I and II:

Drug  Schedule 
N-Ethylamphetamine (1475)  I
Tetrahydrocannabinols (7370) I
2,5-Dimethoxyamphetamine (7396)  I
3,4-Methylenedioxyamphetamine (7400)  I
4-Methoxyamphetamine (7411)  I
Amphetamine (1100) II
Methamphetamine (1105) II
Methylphenidate (1724) II
Codeine (9050) II
Hydromorphone (9150) II
Hydrocodone (9193) II
Methadone (9250) II
Methadone Intermediate (9254) II
Morphine (9300) II
Sufentanil (9740) II
Fentanyl (9801) II

The company plans to manufacture the listed controlled substances in bulk for distribution to its customers.

No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Cambrex North Brunswick, Inc., Technology Centre of New Jersey to manufacture the listed basic classes of controlled substances is consistent with the public interest at this time. DEA has investigated Cambrex North Brunswick, Inc., Technology Centre of New Jersey to ensure that the company's registration is consistent with the public interest. The investigation has included inspection and testing of the company's physical security systems, verification of the company's compliance with state and local laws, and a review of the company's background and history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of the basic classes of controlled substances listed.

Dated: February 23, 2005.

William J. Walker, 
Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.

[FR Doc. 05-4212 Filed 3-3-05; 8:45 am]

BILLING CODE 4410-09-P

NOTICE: This is an unofficial version. An official version of these publications may be obtained directly from the Government Printing Office (GPO).

Back to Top


Registration Support  
Toll Free Number: 1-800-882-9539

ARCOS
| Career Opportunities | Chemical Program | Controlled Substance Schedules | Drugs and Chemicals of Concern  
Electronic Commerce Initiatives |  | Federal Register Notices | Import Export | Links | Meetings and Events | NFLIS
Offices & Directories | On-Line Forms & Applications | Program DescriptionPublications | Questions & Answers | Quotas  
  Reports Required by 21 CFR | Title 21 Regulations & Codified CSA
   Contact Us | HomeHot Items | Site Map | Search | What's New